The Worldwide IVF Services Industry is Expected to Reach $31+ Billion by 2027

DUBLIN, July 30, 2021 /PRNewswire/ — The “IVF Services Market Forecast to 2027 – COVID-19 Impact and Global Analysis By Cycle Type (Fresh IVF Cycles, Thawed IVF Cycles, and Donor Egg IVF Cycles); End User (Fertility Clinics, Hospitals, and Surgical Centers and Clinical Research Institutes), and Geography” report has been added to’s offering.

The global IVF services market is expected to reach US$ 31,613.76 million by 2027 from US$ 13,496.29 million in 2019. It is estimated to grow at a CAGR of 11.2% from 2019 to 2027.

Fertility clinics are among medical clinics that support couples as well as individuals who want to conceive pregnancy but have been unable to achieve this goal through the natural course for medical reasons. There are several fertility clinics and services offered in North American and European counties to prevent infertility. Assisted reproductive technology (ART) now produces more than 50,000 babies per year in the US through 330,000 IVF procedures. Demand is growing from the ranks of more than seven million infertile women, many of which delayed childbearing due to careers. In the US, there are about 450 fertility clinics, more than 100 sperm banks, an unknown number of egg donors, and 1,700 reproductive endocrinologists competing for the business. IntegraMed and Prelude Fertility exist in two large chains, as most programs are run by small MD practices or are part of a hospital or University. Various government initiatives and changes in the legal system drive the demand for assisted reproduction procedures in clinics. In the US, around 14 states cover infertility treatment under medical insurance. In Canada, the government is initiating measures to control the declining population, wherein it has sponsored various cycles of artificial insemination and IVF.

Based on cycle type, the IVF services market is segmented into fresh IVF cycles, thawed IVF cycles, and donor egg IVF cycles. The fresh IVF cycles segment held the largest share of the market in 2019, as it has been used for decades in IVF treatment with a great success. One big advantage of a fresh embryo transfer is that it is a shorter process to conceive pregnancy (if the procedure is successful). This advantage of fresh IVF cycles is likely to have a positive impact on the adoption of the procedure. Moreover, high success rate of the IVF procedure in its first attempt would further propel the market growth for the fresh IVF cycles segment at the fastest CAGR during the forecast period.

Based on end user, the IVF services market is segmented into hospitals, fertility clinics, and surgical centers and clinical research institutes. The fertility clinics segment held the largest market share in 2019, and the same segment is expected to register the highest CAGR in the market during the forecast period.

Key Topics Covered:

1. Introduction

2. IVF Services Market – Key Takeaways

3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Global IVF Services- Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America – PEST Analysis
4.2.2 Europe – PEST Analysis
4.2.3 Asia Pacific – PEST Analysis
4.2.4 Middle East and Africa (MEA) – PEST Analysis
4.2.5 South and Central America (SCAM) – PEST Analysis
4.3 Expert Opinions

5. IVF Services Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Incidence of Infertility
5.1.2 Rising Number of Fertility Clinics and Infertility Services with Government Support
5.1.3 Growing Number of Product Launches and Developments
5.2 Market Restraints
5.2.1 High Procedural Cost of Reproductive Techniques
5.2.2 Risks Associated with Infertility Treatment
5.3 Market Opportunities
5.3.1 Conduction of Awareness Campaigns
5.4 Future Trends
5.4.1 Integration of Artificial Intelligence (AI) in In Vitro Fertilization
5.5 Impact analysis

6. IVF Services Market – Global Analysis
6.1 Global IVF Services Marker Revenue Forecast And Analysis
6.2 Global IVF Services Market, By Geography – Forecast And Analysis
6.3 Market Positioning of Key Players

7. IVF Services Market Analysis – By Cycle Type
7.1 Overview
7.2 IVF Services Market Revenue Share, by Cycle Type (2019 and 2027)
7.3 Fresh IVF Cycles
7.3.1 Overview
7.3.2 Fresh IVF Cycles: IVF Services Market – Revenue and Forecast to 2027 (US$ Million)
7.4 Thawed IVF Cycles
7.4.1 Overview
7.4.2 Thawed IVF Cycles: IVF Services Market – Revenue and Forecast to 2027 (US$ Million)
7.5 Donor Egg IVF Cycles
7.5.1 Overview
7.5.2 Donor Egg IVF Cycles: IVF Services Market – Revenue and Forecast to 2027 (US$ Million)

8. IVF Services Market Analysis – By End User
8.1 Overview
8.2 IVF Services Market Share, by End User, 2019 and 2027, (%)
8.3 Fertility Clinics
8.3.1 Overview
8.3.2 Fertility Clinics: IVF Services Market – Revenue and Forecast to 2027 (US$ Million)
8.4 Hospitals
8.4.1 Overview
8.4.2 Hospitals: IVF Services Market – Revenue and Forecast to 2027 (US$ Million)
8.6 Surgical Centers and Clinical Research Institutes
8.6.1 Overview
8.6.2 Surgical Centers and Clinical Research Institutes: IVF Services Market – Revenue and Forecast to 2027 (US$ Million)

9. IVF Services Market Analysis and Forecasts To 2027 – Geographical Analysis

10. Impact of COVID-19 Pandemic on Global IVF Services Market
10.1 North America: Impact Assessment of COVID-19 Pandemic
10.2 Europe: Impact Assessment Of COVID-19 Pandemic
10.3 Asia Pacific: Impact Assessment of COVID-19 Pandemic
10.4 Rest of the World: Impact Assessment of COVID-19 Pandemic

11. IVF Services Market- Industry Landscape
11.1 Overview
11.2 Growth Strategies Done by the Companies in the Market, (%)
11.3 Organic Developments
11.3.1 Overview
11.4 Inorganic Developments
11.4.1 Overview

12. Company Profiles
12.1 Max Healthcare
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Bloom IVF
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 CCRM Fertility.
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Create Health (Create Fertility)
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Medic over
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Aevitas Fertility Clinic
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 BIOART Fertility Clinic
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Prelude Fertility, Inc.
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Gift ov life
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments

13. Appendix

For more information about this report visit

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]   

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1904
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets

Related Links

Leave a comment

Your email address will not be published. Required fields are marked *